))
Vince Sanders and the Impact of FDA Inaction on Hemp at Retail
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on August 11, 2025 16:35 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 357811725 series 2965541
Content provided by Jonathan Miller and Jonathan Miller - National Leading Hemp Attorney. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Jonathan Miller and Jonathan Miller - National Leading Hemp Attorney or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Jonathan Miller interviews Vince Sanders, CEO of American Shaman, about FDA's actions and inaction and the impact on the future of the hemp and CBD industries. If you have questions about the episode or ideas for Hemp related topics, email us at [email protected].
Hemp Industry questions covered in the episode:
- How does American Shaman operate a franchise CBD store business operation and what's been the progress of this model?
- How has FDA's inaction on CBD regulations impacted the retail marketplace?
- What has been American Shaman's response to the growth of minor cannabinoids such as delta-8 THC?
- What was the content of FDA's Warning Letter to American Shaman, and how has the company responded?
- How concerned should we be about the future of the hemp and CBD industries?
65 episodes
Share
